NRG-GI008: COLON ADJUVANT CHEMOTHERAPY BASED ON EVALUATION OF RESIDUAL DISEASE (CIRCULATE-US)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Colon Cancer
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- (1) Patients must have histologically/pathologically confirmed Stage IIIA or Stage IIIB colon adenocarcinoma (T1-3, N1/N1c) with R0 resection accordingly to AJCC 8th edition criteria.
- (2) No radiographic evidence of overt metastatic disease within 28 days prior to study entry.
- (3) The patient must have had an en bloc complete gross resection of tumor (curative resection).
You may not be eligible for this study if the following are true:
-
Patients with any of the following conditions are NOT eligible for this study:
- (1) Colon cancer histology other than adenocarcinoma.
- (2) Pathologic, clinical, or radiologic overt evidence of metastatic disease. This includes isolated, distant, or non-contiguous intra-abdominal metastases, even if resected.
- (3) Tumor-related bowel perforation.
- (4) History of bone marrow or solid organ transplantation.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.